| Literature DB >> 29887298 |
Abstract
AIM: To determine normative values for stereoacuity, accommodative and vergence measures for high school populations.Entities:
Keywords: Accommodative measures; Escolares; Estereoagudeza; Mediciones acomodativas; Mediciones de vergencia; Normative values; School children; Stereoacuity; Valores normativos; Vergence measures
Mesh:
Year: 2018 PMID: 29887298 PMCID: PMC6612036 DOI: 10.1016/j.optom.2018.03.005
Source DB: PubMed Journal: J Optom ISSN: 1989-1342
Figure 1A phoropter head attached to a specially designed tripod stand. The set up is ideal for vision screening outreach.
Descriptive statistics for refractive, and vergence measures.
| Clinical measures | N | Mean, SD | 95% CI range | Median | Minim | Maxim | 1st quart | 3rd quart | Skew | Kurtosis |
|---|---|---|---|---|---|---|---|---|---|---|
| 1056 | 65.0 ± 0.94 | 64.33–65.67 | 65.00 | 63.00 | 66.00 | 64.75 | 66.00 | −9.94 | 1.18 | |
| | 1056 | −0.01 ± 0.36 | −0.03–0.02 | 0.00 | −5.5 | 1.75 | 0.00 | 0.00 | −6.22 | 79.11 |
| | 1056 | −0.07 ± 0.25 | −0.08–0.05 | 0.00 | −4.5 | 0.00 | 0.00 | 0.10 | −8.24 | 114.91 |
| | 1056 | −0.94 ± 0.88 | −1.170–0.72 | −0.70 | −6.00 | −1.00 | −1.00 | −1.00 | −2.91 | 10.20 |
| | 1056 | 0.54 ± 0.19 | 0.50–0.59 | 0.50 | 0.00 | 2.00 | 1.00 | 1.00 | 5.00 | 26.50 |
| | 1056 | −1.20 ± 0.83 | −1.53–0.87 | −1.00 | −4.00 | 0.00 | 0.00 | −0.75 | −2.90 | 10.90 |
| 1055 | 43.9 ± 25.23 | 42.42–45.47 | 40.00 | 10.00 | 400 | 32.00 | 50.00 | 4.41 | 47.36 | |
| | 1056 | 6.88 ± 2.88 | 6.71–7.05 | 6.00 | 5.00 | 38.00 | 6.00 | 7.00 | 6.15 | 51.93 |
| | 1056 | 9.48 ± 3.47 | 9.27–9.69 | 9.00 | 6.00 | 44.00 | 8.00 | 10.00 | 5.25 | 38.47 |
| | ||||||||||
| Lateral | 1056 | −0.09 ± 1.71 | −0.02–0.19 | 0.00 | 12,00 | 18.00 | −1.00 | 0.00 | 0.67 | 23.76 |
| Vertical | 1056 | 0.026 ± 0.29 | 0.01–0.05 | 0.00 | −0.50 | 8.00 | 0.00 | 0.00 | 21.27 | 530.24 |
| Lateral | 1056 | −1.78 ± 4.24 | −0.12–0.21 | 1.00 | −15 | −18.00 | 1.00 | 9.00 | 0.26 | 2.16 |
| Vertical | 1056 | 0.03 ± 0.36 | 0.02–0.06 | 0.00 | −2.00 | 8.00 | 0.00 | 0.00 | 14.91 | 279.68 |
| BI break | 1055 | 17.37 ± 5.45 | 17.04–17.7 | 0.18 | 2.00 | 45.00 | 14.00 | 20.00 | 0.66 | 5.02 |
| BI recovery | 1055 | 12.52 ± 4.23 | 12.26–12.77 | 12.00 | 0.00 | 35.00 | 10.00 | 16.00 | 0.07 | 4.45 |
| BO break | 1055 | 25.38 ± 9.16 | 24.82–25.93 | 25.00 | 2.00 | 45.00 | 20.00 | 30.00 | −0.41 | 2.58 |
| BO recovery | 1055 | 17.49 ± 6.77 | 17.09–17.9 | 18.00 | 0.00 | 40.00 | 14.00 | 20.00 | 0.35 | 4.47 |
| AA bin | 1056 | 15.6 ± 3.19 | 15.41–15.8 | 15.00 | 5.00 | 20.00 | 14.00 | 18.00 | −0.58 | 3.11 |
| AF ± 2 mon | 1005 | 8.69 ± 3.41 | 8.48–8.9 | 10.00 | 0.00 | 16.00 | 6.00 | 12.00 | −0.77 | 2.81 |
| AF bin ± 2 | 996 | 8.75 ± 3.46 | 8.53–8.96 | 10.00 | 0.00 | 14.00 | 6.00 | 12.00 | −0.68 | 2.56 |
| AF mon +2 | 1052 | 10.25 ± 3.13 | 10.07–10.44 | 11.00 | 0.00 | 18.00 | 10.00 | 12.00 | −1.44 | 4.99 |
| AF bin −2 | 1044 | 9.78 ± 3.35 | 9.57–9.98 | 10.5 | 0.00 | 20.00 | 8.00 | 12.00 | −0.94 | 3.64 |
| AF bin +2 | 1044 | 10.39 ± 3.22 | 10.2–10.59 | 11.5 | 0.00 | 19.00 | 9.00 | 12.00 | −1.26 | 4.37 |
| AF mon −2 | 1044 | 9.78 ± 3.25 | 9.58–9.97 | 10.00 | 0.00 | 20.00 | 8.00 | 12.00 | −0.98 | 3.93 |
| AR | 1051 | 0.55 ± 0.21 | 0.54–0.56 | 0.50 | –0.75 | 1.50 | 0.50 | 0.50 | 0.06 | 9.13 |
| NRA | 1055 | 2.17 ± 0.48 | 2.14–2.2 | 2.25 | –2.5 | 3.50 | 2.00 | 2.50 | −2.76 | 21.67 |
| PRA | 1055 | −2.44 ± 0 .71 | −2.49–2.4 | −2.75 | –3.75 | 2.75 | −3.00 | −2.00 | 1.43 | 7.41 |
For lateral phoria, minus denotes exophoria while plus represents esophoria. For vertical phoria, plus values represent hyperphoria. SS = school setting, CS = clinic setting. PU = push up. AT = accommodative target. RL = red lens. PL = pen light. PLRG = pen light, red green.mon = monocular, bin = binocular.
Classification criteria for accommodative anomalies.
| Anomaly types |
|---|
| Minimum of clinical signs (1) and (2), or (1) and (3), or all clinical signs |
| 1) Reduced amplitude of accommodation (AA) |
| 2) High values on monocular estimation method (MEM) retinoscopy >+0.75 D. |
| 3) Fails monocular accommodative facility (MAF) testing with −2.00D with a criterion <6 cycles per minute (cpm). |
| Clinical signs (1) and (2), or (1) and (3) |
| 1) Low MEM <+0.25 D. |
| 2) Difficulty clearing +2.00 D with MAF with a criterion <6 cpm. |
| 3) Fails binocular accommodative facility (BAF) test with +2.00 D with a criterion <3 cpm. |
| Clinical signs (1) and (2), or (1) and (3) |
| (1) Fails BAF and MAF using ±2.00 D lenses, with a criteria of MAF <11 cpm, and BAF <8 cpm. |
| (2) Positive relative accommodation (PRA) <−2.00 D. |
| (3) Negative relative accommodation (NRA) <+2.37 D. |
Mean and standard deviation for near point of convergence and stereoacuity from previous studies.
| Authors and reference numbers | Country of study | Study setting | Age | Sample size | Technique | Near point of convergence | |
|---|---|---|---|---|---|---|---|
| Mean SD | Mean SD | ||||||
| Break | Recovery | ||||||
| Present study | South Africa | SS | 13–18 | 1056 | PU | 6.8 ± 2.8 | 9.48 ± 3.4 |
| Metsing | South Africa | SS | 8–13 | 112 | PU | 4.9 ± 2.3 | N/A |
| Jimenez et al. | Spain | SS | 6–12 | 1056 | PU with RL | 6.5 ± .7 | 14.3 ± 11.2 |
| Abraham et al. | India | SS | 10–18 | 150 | AT/PLRG | 7.17 ± 3.1 | 8.63 ± 3.2 |
| Hussaindeen et al. | India | SS | 7–13 | 920 | PU/PL | 3 ± 3/7 ± 5.1 | 4 ± 4/10 ± 7 |
| Hayes et al. | US | SS | KG, 3rd 6th | 297 | PU | 4.3 ± 3.4 | 7.2 ± 3.9 |
| Maples et al. | USA | SS | 8–13 | 539 | PU | 4.2 ± 3.4 | 9.8 ± 4.0 |
| Brent and David | USA | SS | 10–14 | 126 | PU | 5.0 ± 0.2 | N/A |
| Borsting et al. | USA | SS | 8–13 | 14 | PU | 3.92 ± 3.9 | 6.73 ± 5.13 |
| Scheiman et al. | USA | CS | 22–37 | 175 | PLRG | 2.3 ± 2.1 | 4.35 ± 3.2 |
| Yekta et al. | Iran | SS | 18–35 | 382 | PU | 5.2 ± 3.6 | N/A |
| Lanca and Rowe | Portugal | SS | 6–14 | 530 | PU | 6.0 ± 0.3 | Not reported |
| Present study | South Africa | SS | 13–18 | 1056 | Randot stereo-test | 43.9 ± 25.2 | |
| Jimenez | Spain | SS | 6–12 | 1056 | Randot stereo-test | 22 ± 6 | |
| Hussaindeen et al. | India | SS | 7–17 | 920 | Randot stereo-test | 40 ± 1 | |
| Almubrad | Saudi Arabia | SS | 6–12 | 1383 | Titmus | 43.3 ± 9.2 | |
| Oduntan et al. | Saudi Arabia | SS | 6–12 | 855 | Randot stereo-test | 25.3 ± 9.9 | |
| Farvardin1 and Afarid | Iran | SS | 6–12 | 1000 | Randot stereo-test | 71.7 ± 54.7 | |
| Guo et al. | China | SS | 4–18 | 5780 | Titmus | 50.2 ± 50.6 | |
Summary of findings on means and standard deviations for lateral heterophoria at far and near fixations.
| Authors/Ref number | Country of study | Study Setting | Age (years) | Sample size | Technique | Far horizontal (pd) | Near horizontal pd |
|---|---|---|---|---|---|---|---|
| Present study | South Africa | SS | 13–18 | 1056 | von Graefe | −0.1 ± 1.7 | −1.7 ± 4.2 |
| Mathebula | South Africa | CS | 20–36 | 139 | von Graefe | N/A | −2.1 ± 6.2 |
| Mathebula | South Africa | SS | 6–13 | 900 | Maddox rod | −0.2 ± 1.1 | −2.5 ± 2.3 |
| Makgaba | South Africa | CS | 18–38 | 336 | von Graefe | −0.7 ± 2.8 | −3.8 ± 4.8 |
| Morgan | USA | CS | Prepresbyopes | 800 | von Graefe | −1 ± 2 | −3 ± 3 |
| OEP | USA | CS | Adults | Thousands | von Graefe | −0.5 (SD N/A) | −6 |
| Haines | USA | CS | Presbyopes | 500 | von Graefe | 0 ± 1 | −4.8 ± 3.2 |
| Betts and Austin | USA | SS | 10–14 | 126 | −3 ± 2.0 | ||
| Shephard | USA | CS | Adult & children | 2000 | – | −1 ± 2.5 | −5 ± 5 |
| Jackson and Goss | USA | CS | 7.9–15.9 | 244 | von Graefe | −1 ± 2 | −3.0 ± 4.0 |
| Saladin and Sheedy | USA | SS | 20–30 years | 103 | von Graefe | 1.0 ± 3.5 | 0.5 ± 6 |
| Lyon et al. | USA | SS | 6–11 | 879 | M/Thorington | 2 | −1 ± 4.0 |
| Jimenez et al. | Spain | SS | 6–12 | 1056 | M/Thorington | + 0.7 ± 4.4 (eso) | −0.1 ± 3.8 |
| Lanca and Rowe | Portugal | SS | 6–14 | 530 | Cover test | −0.1 ± 0.6 | −1.8 ± 2.6 |
| Leone et al. | Australia | SS | 6–12 | 4093 | Cover test | N/A | −3.9 |
| Chen et al. | Malaysia | SS | 2–15 | 268 | Maddox wing | N/A | −1.3 |
| Chen and Abidin | Malaysia | SS | 7–12 | 60 | Howard Card | −0.2 ± 0.8 | −1.8 ± 3.9 |
| Razavi et al. | Iran | CS | 20–40 university students | 111 | Maddox wing | N/A | −2.2 ± 3.0 |
| Yekta et al. | Iran | SS | 18–35 university students | 382 | CT | −1.1 ± 2.0 | −5.0 ± 4.7 |
Values in minus sign = exophoria. N/A = information is not available.
Summary of means and standard deviation for near fusional vergences from present study and available studies reviewed.
| Authors/reference number | Country of study | Study setting | Participants’ age/range | Sample size | Fusional vergences | ||||
|---|---|---|---|---|---|---|---|---|---|
| Technique | Negative fusional vergence | Positive fusional vergence | |||||||
| Break | Recovery | Break | Recovery | ||||||
| Present study | South Africa | SS | 13–18 | 1056 | PB | 17.3 ± 5.4 | 12.5 ± 4.2 | 25.3 ± 9.1 | 17.5 ± 6.7 |
| Mathebula | South Africa | CS | 20–36 | 139 | RP | 22.9 ± 8.0 | 11.3 ± 6.1 | 24.7 ± 7.0 | 11.3 ± 5.5 |
| Morgan | USA | CS | Prepresbyopes | 800 | RP | 21 ± 4 | 13 ± | 21 ± 6 | 11 ± 7 |
| OEP | USA | CS | Adults | Thousands | RP | 22 | 18 | 21 | 15 |
| Haines | USA | CS | Prepresbyopes | 500 | N/A | 22 | N/A | 23 | N/A |
| Betts and Austin | USA | SS | 10–14 years | 126 | N/A | 22 ± 4 | 12 ± 6 | 22 ± 6 | 6 ± 7 |
| Shepard | USA | CS | Adults & children | 2000 | N/A | 20 ± 5.5 | 11 ± 4 | 25 ± 11 | 13 ± 7.5 |
| Wessons | USA | CS | 4–70 | 116 | PB | 13 ± 5 | 10 ± 4 | 19 ± 11 | 14 ± 9 |
| Scheiman et al. | USA | CS | 7–12 | 386 | PB | 12 ± 5 | 7 ± 4 | 23 ± 8 | 16 ± 6 |
| Jackson and Goss | USA | CS | 7.9–15.9 | 244 | RP | 21 ± 4 | 9 ± 4 | 27 ± 8 | 16 ± 6 |
| Saladin and Sheedy | USA | SS | University students | 103 | RP | 19 ± 7 | 13 ± 6 | 30 ± 12 | 23 ± 11 |
| Lyon et al. | USA | SS | 6–11 | 879 | PB | 16 ± 7 | 10 ± 5 | 21 ± 11 | 13 ± 8 |
| Jimenez et al. | Spain | SS | 6–12 | 1056 | PB | 11 ± 3 | 7 ± 3 | 18 ± 3 | 13 ± 6 |
| Lanca and Rowe | Portugal | SS | 6–14 | 530 | PB | 9.7 ± 1.9 | N/A | 20.2 ± 5.0 | N/A |
| Hussaindeen et al. | India | SS | 7–17 | 920 | PB | 15 ± 4 | 11 ± 4 | 26 ± 10 | 21 ± 10 |
| Chen and Abidin | Malaysia | SS | 7–12 | 60 | PB | NA | N/A | 19.4 ± 9.4 | 14.6 ± 8.9 |
| Yekta et al. | Iran | SS | 18–35 (university students) | 382 | PB | 18.6 ± 4.9 | 13.9 ± 3.7 | 31.4 ± 6.7 | 22. 8 ± 6.0 |
| Razavi et al. | Iran | CS | 20–40 (university students) | 111 | 13.8 ± 4.9 | 10.5 ± 4 .5 | 15.5 ± 6.2 | 12.40 ± 6.1 | |
Means and standard deviations on accommodative measures from reviewed studies.
| Country of Study | Study setting | Age (years) | Sample size | Amplitude of accommodation | AF binocular | AR (lag) | Relative accommodation | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Technique | Mean/SD | Techn | Mean/SD | Tech | Mean/SD | NRA | PRA | |||||
| Present study | S/Africa | SS | 13–18 | 1056 | PU | 15.6 ± 3.1 | ±2 | 8.7 ± 3.4 | MEM | 0.3 ± 0.3 | 2.1 ± 0.4 | −2.4 ± 0.7 |
| Metsing and Ferrari | S/Africa | SS | 8–13 | 112 | PU | 13.7 ± 4.1 | ±2 | 5.8 ± 2.6 | ||||
| Moodley | S/Africa | SS | 6–13 | 264 | PU | 13 ± 3.8 | ±2 | 5.6 ± 1.1 | MEM | 0.3 ± 0.3 | ||
| Ogbomo et al. | Nigeria | SS and CS | 6–16 | 688 | PU | 15.8 ± 3.4 | – | – | – | – | ||
| Ogbomo et al. | Ghana | SS | 8–14 | 435 | PU | 16.8 ± 3.0 | – | – | – | – | ||
| Morgan | USA | CS | Prepresbyopes | 800 | – | – | – | – | MEM | 1.3 ± 0.3 | 2.0 ± 0.5 | −2.3 ± 1.1 |
| Haines | USA | CS | Presbyopes | 500 | – | – | – | – | MEM | 1.0 ± 0.4 | 2.06 ± 0.2 | 2.0 ± 0.4 |
| Shepard | USA | CS | Ad and children | 2000 | – | – | – | – | – | – | – | – |
| OEP | USA | CS | 2.0 | −2.2 | ||||||||
| Brent and Austin | USA | SS | 10–14 | 126 | 8.3 ± 2.7 | – | – | – | – | 2.1 ± 0.6 | −4.8 ± 2.3 | |
| Rouse and Hutter | USA | 4–12 | 721 | – | – | – | – | MEM | 0.3 ± 0.3 | |||
| Jackson and Goss | USA | CS | 7.9–15.9 | 244 | – | – | ±2 | 7.8 ± 8.0 | MEM | 0.2 ± 0.2 | 1.9 ± 0.5 | −2.1 ± 1.3 |
| Zeller | USA | SS | 18–30 | 100 | – | – | 7.7 ± 5.2 | |||||
| Hennessey | USA | SS | 8–14 | 60 | – | – | ±2. | 7.8 ± 8.0 | ||||
| Rouse et al. | USA | 10–18 | 40 | – | – | ±2 | 10.3 ± 5.5 | – | – | – | – | |
| Scheiman et al. | USA | 8–12 | 542 | – | – | ±2 | 5.0 ± 2.5 | – | – | – | – | |
| Taub and Sallo-Ho | USA | 6–13 | PU | 15.4 | – | – | – | – | – | – | ||
| Sterner et al. | Sweden | SS | 6–10 | 76 | 15.2 ± 3.8 | ±2 | – | – | ||||
| Gierow et al. | Sweden | SS | 8–13 | 42 | PU | 13.5 ± 1.9 | ±2 | 5.5 ± 3.9 | ||||
| Jimenez | Spain | SS | 6–12 | 1056 | ±2 | 4.1 ± 2.5 | MEM | 0.3 ± 0.4 | – | – | ||
| McClelland | Ireland | 4–15 | 125 | – | – | – | – | Nott | 0.3 ± 0.3 | – | – | |
| Hussaindeen et al. | India | SS | 7–17 | 920 | 11 ± 3 | ±2 | 14 ± 5 | 0.4 ± 0.2 | – | – | ||
| Abraham et al. | India | 10–18 | 150 | MLB | 9.9 ± 1.7 | – | – | – | – | – | – | |
| Yekta et al. | Iran | 18–35 | 382 | PU | 11.1 ± 2.6 | ±2 | 8.8 ± 4.4 | – | – | 2.0 ± 0.3 | −2.9 ± 0.7 | |
Cited in Scheiman and Wick. Ad = Adult. OEP = Optometric Extension Programme. Techn = Technique. Blank spaces indicate that information is not available. PU = push up. MLB = minus lens-to-blur. MEM = monocular estimation method.
Range of normal for stereoacuity, accommodative and vergence measures for present study.
| Clinical measures | Measurement techniques | Mean, SD | Range of normal (±1 SD) to the closest practical number | |
|---|---|---|---|---|
| 1055 | Randot stereo test | 43.95 ± 25.23 | 17 to 69 s arc | |
| | RAF rule/Push Up | |||
| NPC break | 1056 | 6.88 ± 2.88 | 5 to 10 | |
| NPC recovery | 1056 | 9.48 ± 3.47 | 6 to 13 | |
| 1056 | Von Graefe | |||
| | 1056 | |||
| Lateral | 1056 | −0.09 ± 1.71 | 2 eso to 2 exo | |
| Vertical | 1056 | 0.02 ± 0.29 | Ortho to 0.50 exo | |
| | 1056 | |||
| Near lateral | 1056 | −1.78 ± 4.24 | 2.5 to 6 exo | |
| Near vertical | 1056 | −0.03 ± 0.36 | Ortho to 0.50 exo | |
| | 1056 | Prism bars | ||
| BI break | 1054 | 17.37 ± 5.45 | 12–23 | |
| BI recovery | 1054 | 12.52 ± 4.23 | 8–17 | |
| BO break | 1054 | 25.38 ± 9.16 | 16–35 | |
| BO recovery | 1054 | 17.49 ± 9.16 | 11–24 | |
| | ||||
| Amplitude of accommodation (D) | 1056 | Royal Air force rule, with push up | 15.6 ± 3.19 | 12 to 18 |
| Accommodative response (D) | 1051 | Monocular estimation method | 0.55 ± 0 .21 | Plano to 0.75 |
| Negative relative accommodation (DS) | 1055 | Plus lenses on Phoropter | 2.17 ± 0.48 | 1.7 to 2. 5 |
| Positive relative accommodation (DS) | 1055 | Minus lenses on Phoropter | −2.44 ± 0.7 | −2 to −3.0 |
| Binocular accommodative facility (cpm) | 1004 | ±2 flipper lenses | 8.75 ± 3.46 | 5 to 12 |
| AC/A ratio (D) | Calculated | 5.9 ± 0.9 | 5 to 6.80 | |
Range of normal for accommodative and vergence measures in present study compared to findings from available studies.
| Clinical measures | Present study | Haines | Morgan | Scheiman and Wick |
|---|---|---|---|---|
| | 5 to 10 cm | AT: break/2.5 ± 2.5, recovery, 4.5 ± 3.00. | ||
| | 6 to 13 cm | |||
| | ||||
| Lateral | 2 eso to 2 exo | 1 eso to 1 exo | Ortho to 2 exo | 1 ± 2 |
| Vertical | Ortho to 0.50 pd | less than 1 exo | N/A | N/A |
| Near lateral | 2.5 to 6 pd exo | 2 to 8 exo | 3 ± 3** | 3 ± 3 (from Morgan's data) Orthophoria to 6 exo |
| Near vertical | Ortho to 0.50 exo | N/A | ||
| | For step vergences | |||
| Base in break | 12–23 pd | 19 to 25 | 19 to 23 | 13 ± 6 |
| Base in recovery | 8–17 pd | 8 to 18 | 10 to 16 | 10 ± 5 |
| Base out break | 16–35 pd | 17 to 28 | 18 to 24 | 19 ± 9 |
| Base out recovery | 11–24 pd | 12 to 22 | 7 to 15 | 14 ± 7 |
| | ||||
| Amplitude of accommodation (D) | 16 ± 3 | Based on Donder's Table. | Based on Duane s table | Based on Hoffsteters minimum expected |
| Accommodative response (D) | Plano to 0.75 DS | 0.62 to 1.50 | 1.25 to 1.50 | + 0.50 ± 0.25 (1 SD) |
| Binocular accommodative facility (cpm) | 5 to 12 cpm | N/A | N/A | 10 ± 5.0 cpm (1 SD) |
| Negative relative accommodation (DS) | 1.7 to 2. 5 DS | 1.75 to 22.5 | 1.75 to 2.25 | + 2.00 ± 0.50 (1 SD) |
| Positive relative accommodation (DS) | −2 to −3.0 DS | −1.50 to −2.75 | −1.75 to −3.00 | −2.37 ± 1.0 (1 SD) |
Correlation of accommodative and vergence measures using the Spearman's rank correlations test. Only variables with significant correlations [(r) at p < 0.05] are shown on the table and most correlations are weak.
| NPC break | Stereoacuity | Near exo | Near eso | BI break | BI recovery | BO break | BO recovery | AA bin | AF bin ± 2 | AR | NRA | PRA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPC break | 1 | – | – | – | – | – | – | – | – | – | – | – | – |
| Stereoacuity | 0.17 | – | – | – | – | – | – | – | – | – | – | – | – |
| Near exo | 0.29 | – | 0.25 | – | – | – | – | – | – | – | – | – | – |
| Near eso | – | 0.08 | −0.24 | −0.32 | – | – | – | – | – | – | – | – | – |
| BI break | – | −0.11 | 0.14 | −0.13 | 1 | – | – | – | – | – | – | – | |
| BI recovery | – | −0.12 | 0.16 | −0.13 | 0.81 | 1 | – | – | – | – | – | – | |
| BO break | −0.14 | −0.14 | −0.09 | −0.09 | 0.06 | 0.46 | 0.32 | 1 | – | – | – | – | – |
| BO recovery | −0.16 | −0.10 | −0.10 | −0.13 | 0.07 | 0.35 | 0.32 | 0.84 | 1 | – | – | – | – |
| AA bin | −0.06 | −0.08 | – | – | – | 0.07 | – | 0.20 | 0.17 | 1 | – | – | – |
| AF bin ± 2 | – | −0.19 | – | – | – | – | – | – | 0.26 | 0.12 | 0.23 | −0.42 | |
| AR | 0.08 | 0.11 | – | – | 0.11 | – | – | −0.11 | −0.12 | −0.43 | −0.19 | 0.08 | 0.29 |
| NRA | −0.18 | −0.16 | – | −0.15 | 0.20 | 0.13 | 0.23 | 0.20 | – | 0.37 | 1 | −0.43 | |
| PRA | 0.19 | 0.17 | – | 0.17 | −0.26 | −0.24 | −0.24 | 0.20 | −0.27 | −0.50 | −0.43 | 1 |
Exo = exophoria.eso = esophoria, BI = base in, BO = base out. AA bin = binocular amplitude of accommodation. AR = accommodative response. AF bin = binocular accommodative facility. NRA = negative relative vergence, PRA = positive relative vergence.
Convergence Insufficiency and Reading Study (CIRS) group's criteria for convergence insufficiency.
| Anomaly types and clinical signs |
|---|
| (1) Exophoria at near. |
| (2) Exophoria at near ≥4 prism diopter (pd) greater than far. |
| (3) Insufficient fusional vergence defined as either (i) fails Sheard's criterion or (ii) poor PFV at near ≤12 pd Base out (BO) to blur or ≤15 pd BO break. Poor BO break was used for insufficient PFV criteria. |
| (4) Receded NPC ≥7.5 cm break or ≥10.5 cm recovery. |
| i. Low suspect CI (exophoria at near ≥4 pd than at far and clinical sign one. |
| ii. High suspect CI (exophoria at near, and 2 signs or clinical sign 1 and 2 plus 3 or 4. |
| iii. Definite CI (all clinical signs must be present). |